Agenus Inc's Form 4 filing
MiNK Therapeutics, Inc. (INKT) · filed Oct 16, 2023
- Accession no.
- 0000950170-23-053601
- Filed
- Oct 16, 2023
- Trade date
- Oct 12-16, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $25.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agenus IncCIK 0001098972 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2023 | Common Stock | PPurchaseAcquired | +3,173 | $1.10 | +$3,490.3 | 21,753,061 | Direct | |
| Oct 13, 2023 | Common Stock | PPurchaseAcquired | +19,373 | $1.10 | +$21,310.3 | 21,772,434 | Direct | |
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +429 | $1.10 | +$471.9 | 21,772,863 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.